QID 317046

Date Published: 2021-09-23

QID 317046: Cisco Internetwork Operating System (IOS) XE Software Rate Limiting Network Address Translation Denial of Service (DoS) Vulnerability (cisco-sa-ratenat-pYVLA7wM)

A vulnerability in the Rate Limiting Network Address Translation (NAT) feature of Cisco IOS XE Software could allow an unauthenticated,
remote attacker to cause high CPU utilization in the Cisco QuantumFlow Processor of an affected device, resulting in a denial of service (DoS) condition.

Affected Products
Cisco IOS XE Software if the Rate Limiting NAT feature is enabled.

QID Detection Logic (Authenticated):The check matches Cisco IOS XE version retrieved via Unix Auth using "show version" command.
QID Detection Logic (Unauthenticated):
The check matches Cisco IOS XE version retrieved via SNMP or TCP/IP Fingerprint or NTP or Telnet.

A successful exploit could allow the attacker to cause the QuantumFlow Processor utilization to reach 100 percent on the
affected device, resulting in a DoS condition.

CVSS V3 rated as Critical - 8.6 severity.

CVSS V2 rated as Medium - 5 severity.

Solution

Customers are advised to refer to cisco-sa-ratenat-pYVLA7wM for more information.

Vendor References

cisco-sa-ratenat-pYVLA7wM - tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-ratenat-pYVLA7wM

CVEs related to QID 317046

CVE-2021-1624 |

Software Advisories

Advisory ID	Software	Component	Link
cisco-sa-ratenat-pYVLA7wM			tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-ratenat-pYVLA7wM

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].